E&G Advisors’s Zimmer Biomet ZBH Stock Holding History

E&G Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,532	Closed	-$490K	–	213
2018 Q2	$490K	Buy	+4,532	New	+$493K	0.2%	116

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

E&G Advisors's ZBH Position: Q3 2018 in Review

E&G Advisors sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 4,532 shares — an estimated $490K sold.

E&G Advisors first reported a position in ZBH in Q2 2018 and held it in 1 quarter. The position peaked at $490K in Q2 2018. 892 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

E&G Advisors reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
E&G Advisors sold 4,532 Zimmer Biomet shares in Q3 2018, an estimated $490K.
E&G Advisors first reported a position in Zimmer Biomet in Q2 2018 and held it in 1 quarter.
E&G Advisors's Zimmer Biomet position peaked at $490K in Q2 2018.
892 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on E&G Advisors's 13F filing for Q3 2018, filed 10 Oct 2018.